Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Glenmark Pharma announces progress in its eczema drug investigation

      Glenmark Pharma announces progress in its eczema drug investigation

      Farhat Nasim5 March 2019 8:59 AM IST
      GBR 830 is an investigational, anti-OX40 monoclonal antibody being studied for the treatment of moderate-to-severe atopic dermatitis (AD).PARAMUS:...
      Daiichi Sankyo exploring sale of OTC drugs business, hires JP Morgan- sources

      Daiichi Sankyo exploring sale of OTC drugs business, hires JP Morgan- sources

      Farhat Nasim4 March 2019 9:15 AM IST
      It is considering selling the Daiichi Sankyo Healthcare unit, four people familiar with the matter told Reuters, declining to be identified because...
      BP treatment vasopressin not included in 503B Bulks List; Endo announces FDA decision

      BP treatment vasopressin not included in 503B Bulks List; Endo announces FDA decision

      Farhat Nasim4 March 2019 9:00 AM IST
      The agency's decision renders the sale of compounded products containing vasopressin, a BP treatment unlawful unless manufactured using an...
      US seeks to lower dialysis costs with more home care versus clinics

      US seeks to lower dialysis costs with more home care versus clinics

      Farhat Nasim4 March 2019 8:59 AM IST
      DaVita and Fresenius Medical Care offer two forms of home dialysis: hemodialysis, which requires a machine and special filter much like in clinics,...
      Sanofi officials to be charged over dengue vaccine deaths

      Sanofi officials to be charged over dengue vaccine deaths

      Farhat Nasim3 March 2019 9:45 AM IST
      MANILA: The Philippine Department of Justice on Friday said it had found probable cause to indict officials from French drugmaker Sanofi and former...
      Cancer causing toxin found in Hetero Labs blood pressure pills

      Cancer causing toxin found in Hetero Labs blood pressure pills

      Farhat Nasim3 March 2019 9:30 AM IST
      The FDA said Torrent Pharmaceuticals Ltd is expanding its voluntary recall to include 114 additional lots of losartan-containing medication due to...
      Parkinsons drug trial offers hope for damaged brain cells

      Parkinsons drug trial offers hope for damaged brain cells

      Farhat Nasim3 March 2019 9:00 AM IST
      LONDON: An experimental drug could offer hope for restoring damaged brain cells in Parkinson's patients, scientists said on Wednesday, although they...
      Biocon appoints Christiane Hamacher as CEO of Biocon Biologics India

      Biocon appoints Christiane Hamacher as CEO of Biocon Biologics India

      Farhat Nasim2 March 2019 11:00 AM IST
      "Christiane joins us at a critical inflexion point in the business as we build our stature in the large and growing opportunity for biosimilar...
      Wockhardt gets USFDA nod for Abiraterone Acetate to treat prostate cancer

      Wockhardt gets USFDA nod for Abiraterone Acetate to treat prostate cancer

      Farhat Nasim2 March 2019 9:50 AM IST
      Abiraterone acetate is used to treat men with prostate cancer that has spread to other parts of the body.New Delhi: Pharma and biotech major Wockhardt...
      Lupin launches Ranolazine extended release tablets in US

      Lupin launches Ranolazine extended release tablets in US

      Farhat Nasim2 March 2019 9:45 AM IST
      The newly launched Ranolazine ER tablets, in strengths of 500 mg and 1,000 mg, is a generic version of Gilead Sciences' Ranexa ER tablets, Lupin said...
      Novartis faces shareholder criticism over drug prices at annual general meeting

      Novartis faces shareholder criticism over drug prices at annual general meeting

      Farhat Nasim2 March 2019 9:30 AM IST
      Chief Executive Vas Narasimhan, who did not testify this week before the U.S. Senate with other global drug industry executives also facing criticism...
      Native drugs can control expenses: Chief economic advisor K V Subramanian

      Native drugs can control expenses: Chief economic advisor K V Subramanian

      Farhat Nasim2 March 2019 9:15 AM IST
      Speaking at an interactive session with former Minister and TRS working president KT Rama Rao, Subramanian said there was a necessity to invest in...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok